Keertan Dheda

Active 2004–2025

185
Papers
37,081
Citations
95
h-index
179
i10-index

Citations

Citations per year for Keertan Dheda1974: 1 citations1990: 1 citations1998: 1 citations2004: 2 citations2005: 48 citations2006: 98 citations2007: 91 citations2008: 123 citations2009: 138 citations2010: 162 citations2011: 178 citations2012: 179 citations2013: 180 citations2014: 226 citations2015: 191 citations2016: 182 citations2017: 198 citations2018: 284 citations2019: 1,073 citations2020: 1,063 citations2021: 3,055 citations2022: 1,888 citations2023: 725 citations2024: 1,029 citations2025: 374 citations2026: 22 citations1975–1989: no citations, so these years are not shown1991–1997: no citations, so these years are not shown1999–2003: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,934 citing papers, 16.4% of this breakdownUnited Kingdom: 1,735 citing papers, 9.7% of this breakdownChina: 1,257 citing papers, 7% of this breakdownSouth Africa: 1,068 citing papers, 5.9% of this breakdownIndia: 774 citing papers, 4.3% of this breakdownGermany: 718 citing papers, 4% of this breakdownItaly: 624 citing papers, 3.5% of this breakdownCanada: 564 citing papers, 3.1% of this breakdownSwitzerland: 517 citing papers, 2.9% of this breakdownAustralia: 500 citing papers, 2.8% of this breakdownNetherlands: 468 citing papers, 2.6% of this breakdownFrance: 441 citing papers, 2.5% of this breakdown
0%16.4%Other 35.3%

Fields

  • Medicine77.4%
  • Biochemistry, Genetics and Molecular Biology11.2%
  • Immunology and Microbiology3.2%
  • Social Sciences1.7%
  • Mathematics1.3%
  • Engineering0.8%
  • Other4.4%

Topics

  • Tuberculosis Research and Epidemiology12.9%
  • SARS-CoV-2 and COVID-19 Research9.9%
  • Mycobacterium research and diagnosis4.5%
  • COVID-19 Clinical Research Studies4.5%
  • Infectious Diseases and Tuberculosis3.7%
  • Diagnosis and treatment of tuberculosis3.1%
  • Other61.4%

Coauthors

All papers

Open in search
  1. Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Catherine Hill, Helen Hill, Ian Hirsch, Susanne H. Hodgson, Alane Izu, Susan Jackson, Daniel Jenkin, Carina C. D. Joe, Simon Kerridge, Anthonet Koen, Gaurav Kwatra, Rajeka Lazarus, Alison M. Lawrie, Alice Lelliott, Vincenzo Libri, Patrick Lillie, Raburn M. Mallory, Ana Verena Almeida Mendes, Eveline Pı́polo Milan, Angela M. Minassian, Alastair McGregor, Hazel Morrison, Yama F Mujadidi, Anusha Nana, Peter O’Reilly, Sherman D. Padayachee, Ana Maria Pittella, Emma Plested, Katrina M. Pollock, Maheshi Ramasamy, Sarah Rhead, Alexandre Vargas Schwarzbold, Nisha Singh, Darren Smith, Rinn Song, Matthew D. Snape, Eduardo Sprinz, Rebecca Sutherland, Richard Tarrant, Emma C. Thomson, M. Estée Török, Mark Toshner, David P. J. Turner, Johan Vekemans, Tonya Villafana, Marion Watson, Christopher J. Williams, Alexander D. Douglas, Adrian V. S. Hill, Teresa Lambe, Sarah C. Gilbert, Andrew J. Pollard, Marites Aban, Fatola Abayomi, Kushala W.M. Abeyskera, Jeremy Aboagye, Matthew Adam, Kirsty Adams, James P. Adamson, Yemi Adelaja, Gbadebo Adewetan, Syed Adlou, Khatija Ahmed, Yasmeen Akhalwaya, Saajida Akhalwaya, Andrew Alcock, Aabidah Ali, Elizabeth Allen, Lauren Allen, Thamires C. D. S. C Almeida and 665 more - The Lancet 2020 cited by 5,010

  2. Tuberculosis

    Authors: , , , , , , , , , , , - Nature Reviews Disease Primers 2016 cited by 1,239

  3. Incipient and Subclinical Tuberculosis: a Clinical Review of Early Stages and Progression of Infection

    Authors: , , , , , , , , , - Clinical Microbiology Reviews 2018 cited by 578

  4. Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Catherine Green, Christopher Green, Melanie Greenland, Catherine Hill, Helen Hill, Ian Hirsch, Alane Izu, Daniel Jenkin, Carina C. D. Joe, Simon Kerridge, Anthonet Koen, Gaurav Kwatra, Rajeka Lazarus, Vincenzo Libri, Patrick Lillie, Natalie G. Marchevsky, Richard P. Marshall, Ana Verena Almeida Mendes, Eveline Pı́polo Milan, Angela M. Minassian, Alastair McGregor, Yama F Mujadidi, Anusha Nana, Sherman D. Padayachee, Daniel J. Phillips, Ana Maria Pittella, Emma Plested, Katrina M. Pollock, Maheshi Ramasamy, Adam Ritchie, Hannah Robinson, Alexandre Vargas Schwarzbold, Darren Smith, Rinn Song, Matthew D. Snape, Eduardo Sprinz, Rebecca Sutherland, Emma C. Thomson, M. Estée Török, Mark Toshner, David P. J. Turner, Johan Vekemans, Tonya Villafana, Thomas White, Christopher J. Williams, Alexander D. Douglas, Adrian V. S. Hill, Teresa Lambe, Sarah C. Gilbert, Andrew J. Pollard, Marites Aban, Kushala W.M. Abeyskera, Jeremy Aboagye, Matthew Adam, Kirsty Adams, James P. Adamson, Gbadebo Adewatan, Syed Adlou, Khatija Ahmed, Yasmeen Akhalwaya, Saajida Akhalwaya, Andrew Alcock, Aabidah Ali, Elizabeth Allen, Lauren Allen, Felipe B. Alvernaz, Fabio Santos Amorim, Claudia Sala Andrade, Foteini Andritsou, Rachel Anslow and 666 more - The Lancet 2021 cited by 1,208

  5. Efficacy of the ChAdOx1 nCoV-19 Covid-19 Vaccine against the B.1.351 Variant

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Andrew Moultrie, Suzette Oelofse, Faeezah Patel, Sureshnee Pillay, Sarah Rhead, Hylton Rodel, Lindie Rossouw, Carol Taoushanis, Houriiyah Tegally, Asha Thombrayil, Samuel van Eck, Constantinos Kurt Wibmer, Nicholas M. Durham, Elizabeth J. Kelly, Tonya Villafana, Sarah C. Gilbert, Andrew J. Pollard, Túlio de Oliveira, Penny L. Moore, Alex Sigal, Alane Izu - New England Journal of Medicine 2021 cited by 1,321

  6. The intersecting pandemics of tuberculosis and COVID-19: population-level and patient-level impact, clinical presentation, and corrective interventions

    Authors: , , , , , , , , , , , , , , , , , , , , - The Lancet Respiratory Medicine 2022 cited by 307

  7. Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data meta-analysis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jennifer Flood, Gregory J. Fox, M. Jachym, Geisa Fregona, Regina Gayoso, Medea Gegia, Maria Tarcela Gler, Sue Gu, Lorenzo Guglielmetti, Timothy H. Holtz, Jennifer Hughes, Petros Isaakidis, Leah G. Jarlsberg, Russell R. Kempker, Salmaan Keshavjee, Faiz Ahmad Khan, Maia Kipiani, Serena P. Koenig, Won‐Jung Koh, Afrânio Lineu Kritski, Līga Kukša, Charlotte Kvasnovsky, Nakwon Kwak, Zhiyi Lan, Christoph Lange, Rafael Laniado-Laborı́n, Myungsun Lee, Vaira Leimane, Chi‐Chiu Leung, Eric Chung-Ching Leung, Pei Zhi Li, Phil Lowenthal, Ethel Leonor Nóia Maciel, Suzanne M. Marks, Sundari Mase, Lawrence Mbuagbaw, Giovanni Battista Migliori, Vladimir Milanov, Ann C. Miller, Carole D. Mitnick, Chawangwa Modongo, Erika Mohr-Holland, Ignacio Monedero, Payam Nahid, Norbert Ndjeka, Max R. O’Donnell, Nesri Padayatchi, Domingo Palmero, Jean W. Pape, Laura Jean Podewils, Ian S. Reynolds, Vija Riekstiņa, J. Robert, M. J. Rodríguez, Barbara Seaworth, Kwonjune J. Seung, Kathryn Schnippel, Tae Sun Shim, Rupak Singla, Sarah E. Smith, Giovanni Sotgiu, Ganzaya Sukhbaatar, Payam Tabarsi, Simon Tiberi, Anete Trajman, Lisa Trieu, Zarir Udwadia, Tjip S. van der Werf, Nicolas Véziris, Piret Viiklepp and 8 more - The Lancet 2018 cited by 639

  8. The epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant, extensively drug-resistant, and incurable tuberculosis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Gavin Churchyard, Dick Menzies, Anneke C. Hesseling, Eric Nuermberger, Helen McIlleron, Kevin P. Fennelly, Eric Goemaere, Ernesto Jaramillo, Marcus Low, Carolina Morán Jara, Nesri Padayatchi, Robin M. Warren - The Lancet Respiratory Medicine 2017 cited by 679

  9. Multidrug-resistant tuberculosis

    Authors: , , , , , , , , , , , - Nature Reviews Disease Primers 2024 cited by 205

  10. Efficacy of NVX-CoV2373 Covid-19 Vaccine against the B.1.351 Variant

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Aliasgar Esmail, Friedrich G. Petrick, Aylin Oommen-Jose, Sharne Foulkes, Khatija Ahmed, Asha Thombrayil, Lou Fries, Shane Cloney-Clark, Mingzhu Zhu, Chijioke Bennett, Gary Albert, Emmanuel A. Faust, Joyce S. Plested, Andreana Robertson, Susan Neal, Iksung Cho, Greg Glenn, Filip Dubovsky, Shabir A. Madhi - New England Journal of Medicine 2021 cited by 662

  11. Management of drug-resistant tuberculosis

    Authors: , , , , , - The Lancet 2019 cited by 301

  12. Bedaquiline resistance in patients with drug-resistant tuberculosis in Cape Town, South Africa: a retrospective longitudinal cohort study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - The Lancet Microbe 2023 cited by 101

  13. Tuberculosis

    Authors: , , - The Lancet 2015 cited by 599

  14. Anaerobic Bacterial Fermentation Products Increase Tuberculosis Risk in Antiretroviral-Drug-Treated HIV Patients

    Authors: , , , , , , , , , , , , , , , - Cell Host & Microbe 2017 cited by 152

  15. An All-Oral 6-Month Regimen for Multidrug-Resistant Tuberculosis: A Multicenter, Randomized Controlled Clinical Trial (the NExT Study)

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - American Journal of Respiratory and Critical Care Medicine 2022 cited by 95

  16. Xpert MTB/RIF Ultra and Xpert MTB/RIF assays for extrapulmonary tuberculosis and rifampicin resistance in adults

    Authors: , , , , , , , - Cochrane Database of Systematic Reviews 2021 cited by 210

  17. Gamma Interferon Release Assays for Detection of Mycobacterium tuberculosis Infection

    Authors: , , , , , , , , , , - Clinical Microbiology Reviews 2014 cited by 888

  18. Real-time RT-PCR normalisation; strategies and considerations

    Authors: , , , - Genes and Immunity 2005 cited by 1,882

  19. An automated tuberculosis screening strategy combining X-ray-based computer-aided detection and clinical information

    Authors: , , , , , , , - Scientific Reports 2016 cited by 154

  20. Recent advances in the treatment of tuberculosis

    Authors: , , , , , , , , , , , , , , , , , , , , , - Clinical Microbiology and Infection 2023 cited by 116

  21. MDR/XDR-TB management of patients and contacts: Challenges facing the new decade. The 2020 clinical update by the Global Tuberculosis Network

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Borisov Se, Judith Bruchfeld, J. Cadiñanos Loidi, José A. Caminero, Anna Cristina Calçada Carvalho, José Joaquín Cebrián Gallardo, Charalampos, Edvardas Danila, Lina Davies Forsman, Justin T. Denholm, Keertan Dheda, Roland Diel, Saulius Diktanas, Claudia C. Dobler, Martin Enwerem, Susanna Esposito, Nancy Salinas, Filippov Av, Beatrice Formenti, José-María García-García, Delia Goletti, R. Gomez Rosso, Gina Gualano, Petros Isaakidis, Anna Kaluzhenina, S Koirala, Līga Kukša, Heinke Kunst, Yawei LI, Cécile Magis-Escurra, Vinicio Manfrin, Selene Manga, K. Manika, Valentina Marchese, Elena Martínez Robles, А. O. Мaryandyshev, Alberto Matteelli, Alessandro Wasum Mariani, Jesica Mazza‐Stalder, Fernanda Carvalho de Queiroz Mello, Lourdes Milagros Mendoza, A. Mesi, Skaidrius Miliauskas, H. Mustafa Hamdan, Norbert Ndjeka, M. Nieto Marcos, T.H.M. Ottenhoff, Domingo Palmero, Fabrizio Palmieri, Apostolos Papavasileiou, M. C. Payen, Agostina Pontarelli, Margareth Pretti Dalcolmo, Sarai Quirós Fernández, R. Romero, D. Rossato Silva, Adonis Pino Santos, Barbara Seaworth, М. В. Синицын, Alena Skrahina, Ivan Solovič, Antonio Spanevello, Marina Tadolini, Chelseah Denise H. Torres, Zarir Udwadia, Martin van den Boom, Grigory Volchenkov, Askar Yedilbayev, R. Zaleskis, J.-P. Zellweger - International Journal of Infectious Diseases 2020 cited by 226

  22. Diagnostic yield of urine lipoarabinomannan and sputum tuberculosis tests in people living with HIV: a systematic review and meta-analysis of individual participant data

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Suzette Oelofse, Didier Laureillard, Mauro Andreotti, Obvious Nchimunya Chilyabanyama, Benjamin Welu, Lucas Molfino, Sekai Chenai Mathabire Rücker, Elisabeth Szumilin, Loide Cossa, Johanna Meléndez, Linda Mbuthini, Max R. O’Donnell, Joseph N Jarvis, Gcobisa Ndlangalavu, Katherine Fielding - The Lancet Global Health 2023 cited by 86

  23. Genome-wide analysis of multi- and extensively drug-resistant Mycobacterium tuberculosis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , David Moore, Nora Mocillo, Stefan Panaiotov, Julian Parkhill, Carlos Penha‐Gonçalves, João Perdigão, Isabel Portugal, Zineb Rchiad, Jaime Robledo, Patricia Sheen, Nashwa Talaat Shesha, F A Sirgel, Christophe Sola, Erivelton Oliveira Sousa, Elizabeth M. Streicher, Paul D. van Helden, Miguel Viveiros, Robin M. Warren, Ruth McNerney, Arnab Pain, Taane G. Clark - Nature Genetics 2018 cited by 428

  24. A standardised method for interpreting the association between mutations and phenotypic drug resistance inMycobacterium tuberculosis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Matthew Ezewudo, Daniela María Cirillo, Marco Schito, Claudio U. Köser, Timothy C. Rodwell - European Respiratory Journal 2017 cited by 333